NCT01693601
- Conditions
- Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +3 more
- Locations
-
- Icahn School of Medicine at Mount Sinai New York, United States
Clinical trial condition
Myeloproliferative Disorders
Explore clinical trials studying Myeloproliferative Disorders. Study availability and eligibility vary by location and protocol.
1,108 public trials
144 recruiting studies
Myeloproliferative Disorders trial results
NCT05286528
- Conditions
- Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukaemia, +11 more
- Locations
-
- Pfizer Budapest, Hungary
NCT03262974
- Conditions
- Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia, +11 more
- Locations
-
- South Egypt Cancer Institute Asyut, Egypt
NCT00571662
- Conditions
- Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia, Blood Protein Disorders, +40 more
- Locations
-
- University of Nebraska Medical Center, Section of Oncology/Hematology Omaha, Nebraska, United States
NCT02916979
- Conditions
- Blood Protein Disorders, Bone Marrow Diseases, Cardiovascular Diseases, +24 more
- Locations
-
- Dartmouth-Hitchcock Medical Center Lebanon, New Hampshire, United States
NCT03096782
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Biphenotypic Leukemia, Acute Leukemia, +59 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Completed
Sotatercept in Treating Patients With Myeloproliferative Neoplasm-Associated Myelofibrosis or Anemia
NCT01712308
- Conditions
- Anemia, Bone Marrow Diseases, Hematologic Diseases, +6 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT02546375
- Conditions
- Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukaemia, +11 more
- Locations
-
- Royal Liverpool Hospital Liverpool, Merseyside, United Kingdom
- Hammersmith Hospital London, United Kingdom
- Nottingham University Hospital Nottingham, United Kingdom
NCT02767388
- Conditions
- Acute Lymphoid Leukemia, Acute Myeloid Leukemia, Blood Protein Disorders, +42 more
- Locations
-
- University of Nebraska Medical Center Omaha, Nebraska, United States
Completed
Observational Study on CML Patients in Any Phase of the Disease Treated With Ponatinib (Iclusig®)
NCT04048564
- Conditions
- Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia, +11 more
- Locations
-
- CHU SUD Reunion GHSR Saint-Pierre, Reunion, France
- CHU Amiens-Picardie- Site SUD Amiens, France
- CHU D'Angers Angers, France
- CH Annecy Annecy, France